Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8285486 | Parkinsonism & Related Disorders | 2018 | 6 Pages |
Abstract
Increasing evidence supports a link between multiple system atrophy and coenzyme Q10 (CoQ10) biosynthesis. However, so far this knowledge was not translated into tangible benefits for affected patients. Poor bioavailability of oral CoQ10 might constitute a major problem. Current research suggests that 4-hydroxybenzoic acid might constitute an interesting alternative treatment option.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Ageing
Authors
Felix Distelmaier,